{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-276872","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.690641+00:00","generated_at":"2026-06-22T09:52:23.555716+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"LifeStance appoints David Bourdon as CFO, J. Michael Bruff to Business Transformation Officer","bullets":["David Bourdon appointed CFO effective Nov 10, 2022; succeeds J. Michael Bruff who becomes Business Transformation Officer.","Bourdon's annual base salary $500k, target bonus 75% of base, $1M stock signing bonus subject to repayment before 4-year anniversary.","Bourdon granted option to purchase 1.25M shares of LFST common stock; 1/3 time-based vesting over 4 years, 2/3 performance-based.","Bruff transition: retains $1.5M sign-on bonus, surrenders ~$1M in shares, accelerated vesting of RSUs and RSAs on effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-276872","json":"https://secwatch.observer/filing/0001193125-22-276872.json","markdown":"https://secwatch.observer/filing/0001193125-22-276872.md","text":"https://secwatch.observer/filing/0001193125-22-276872.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000119312522276872/0001193125-22-276872-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000119312522276872/d414366d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T09:52:23.555716+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c0e4ba0d8","claim":"J. Michael Bruff changed role as leader of its Business Transformation office at LifeStance Health Group, Inc..","evidence_excerpt":"Mr. Bruff will continue to be employed by the Company as the leader of its Business Transformation office.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312522276872/0001193125-22-276872-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"leader of its Business Transformation office"}],"fact_type":"executive_change"},{"claim_id":"bc0bfffb5d","claim":"David Bourdon was appointed as Chief Financial Officer and Treasurer at LifeStance Health Group, Inc..","evidence_excerpt":"On November 2, 2022, the Board of Directors of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) appointed David Bourdon as the Company’s new Chief Financial Officer and Treasurer effective as of November 10, 2022 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000119312522276872/0001193125-22-276872-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}